Cortellis Clinical Trials Intelligence

Cortellis Clinical Trials Intelligence is a Clarivate solution that a trusted, integrated view of the global clinical trial landscape, providing data, analysis, and insights across trials, sites, biomarkers, patient segments, and more. It helps clinical research teams monitor competing studies, benchmark trial performance, and designer smarter trials.

Clinical development professionals rely on Cortellis Clinical Trials Intelligence to help confidently plan and design trials by tracking competitive studies, defining the right endpoints, selecting appropriate biomarkers, and navigating complex country‑specific trial protocols.

Business Development, Portfolio Strategy, and Competitive Intelligence teams use Cortellis Clinical Trials Intelligence to help track competitors’ clinical trial progression, inform drug development strategies, and evaluate in‑licensing and partnering opportunities.

Cortellis Clinical Trials Intelligence helps teams design smarter, more competitive studies by providing a comprehensive, data‑driven view of the global clinical trial landscape. It enables you to analyze comparable trials – including endpoints, eligibility criteria, and reported outcomes – to refine trial protocols and evaluate study complexity.

With Cortellis data and insights, teams can benchmark against successful trials, monitor competing studies in your therapeutic areas, and track critical milestones such as enrollment dates and primary endpoint completion to anticipate challenges earlier and reduce study risk.

Cortellis Clinical Trials Intelligence provides clarity on which endpoints are associated with trial success or failure, helping teams select more effective and evidence-based endpoints for future studies.

To support global clinical research strategy, the platform enables users to compare endpoints and trial performance across countries and regions. In addition, teams can identify ideal patient segments using integrated genetic variant and biomarker insights – allowing organizations to differentiate their therapeutic approach and improve protocol feasibility from the outset.

Cortellis Clinical Trials Intelligence improves competitor monitoring and strengthens competitive strategy by providing a comprehensive view of the global clinical trial landscape. You can track competing trials by disease area, line of therapy, patient segment, recruitment status, mechanism of action and more to see where rivals are investing and how trial strategies are evolving.

The platform also helps you locate active trial sites and view expected end dates so you can assess geographic coverage and timelines across competing programs. By analyzing competitor endpoints, timelines, and site choices, you can identify competitive gaps, anticipate challenges, and adjust your strategy to help reduce risk and accelerate time to market.

Cortellis Clinical Trials Intelligence helps teams optimize site strategy by combining robust epidemiology insights with global site intelligence to pinpoint the best locations for successful enrollment. You can visualize high‑level incidence and prevalence data across regions using interactive heat maps, making it easier to identify areas with strong patient availability and prioritize countries or sites with the highest opportunity.

The platform lets you filter sites by country, trial phase, recruitment status, and experience with specific diseases, biomarkers, patient segments, genetic variants, endpoints, and more — helping you identify locations with proven access to your target patient populations. With integrated U.S. claims data and detailed site‑level histories, you can assess site performance with greater confidence, reviewing past and current trials, recruitment progress, and overall reliability.

Cortellis Clinical Trials Intelligence makes it easy to identify ongoing trials at any given site, so teams can quickly spot where competing studies may impact recruitment. This visibility allows organizations to avoid overcrowded locations, refine enrollment strategies and prioritize sites with strong patient access.

By combining epidemiology coverage, global site intelligence, competitor activity, and performance metrics, the platform supports data‑driven site selection that can help improve study feasibility, strengthen enrollment success, and reduce operational risk.